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Abstract
In 2011, Dutch animal production sectors started recording veterinary antimicrobial consumption. These data are used by
the Netherlands Veterinary Medicines Authority to create transparency in and define benchmark indicators for veterinary
consumption of antimicrobials. This paper presents the results of sector wide consumption of antimicrobials, in the form of
prescriptions or deliveries, for all pig, veal calf, and broiler farms. Data were used to calculate animal defined daily dosages
per year (ADDD/Y) per pig or veal calf farm. For broiler farms, number of animal treatment days per year was calculated.
Furthermore, data were used to calculate the consumption of specific antimicrobial classes per administration route per pig
or veal calf farm. The distribution of antimicrobial consumption per farm varied greatly within and between farm categories.
All categories, except for rose´ starter farms, showed a highly right skewed distribution with a long tail. Median ADDD/Y
values varied from 1.2 ADDD/Y for rose´ finisher farms to 83.2 ADDD/Y for rose´ starter farms, with 28.6 ADDD/Y for white veal
calf farms. Median consumption in pig farms was 9.3 ADDD/Y for production pig farms and 3.0 ADDD/Y for slaughter pig
farms. Median consumption in broiler farms was 20.9 ATD/Y. Regarding specific antimicrobial classes, fluoroquinolones were
mainly used on veal calf farms, but in low quantities: P75 range was 0 – 0.99 ADDD/Y, and 0 – 0.04 ADDD/Y in pig farms. The
P75 range for 3rd/4th-generation cephalosporins was 0 – 0.07 ADDD/Y for veal calf farms, and 0 – 0.1 ADDD/Y for pig farms.
The insights obtained from these results, and the full transparency obtained by monitoring antimicrobial consumption per
farm, will help reduce antimicrobial consumption and endorse antimicrobial stewardship. The wide and skewed distribution
in consumption has important practical and methodological implications for benchmarking, surveillance and future analysis
of trends.
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Introduction
During the first decade of the 21st century, sales of antimicro-
bials for veterinary consumption strongly increased in the
Netherlands. [1] This is partially attributed to the ban of
antimicrobial growth promoters in the European Union, which
was fully effective in 2006. However, factors like intensification of
animal husbandry, increase of farm size, and changing criteria for
animal feed quality, due to e.g. prion prevention and economic
considerations (such as more expensive compounds), have been
suggested to play a role as well. [2-4].
More recently, antimicrobial resistance has become a growing
public health problem as a result of failure of empiric treatment.
[5] Prevalence and spread of antimicrobial resistant commensal
and pathogenic bacteria have increased as a result of the selection
for resistance because of the widespread consumption of antimi-
crobials. Furthermore, the same antimicrobial anatomical thera-
peutic chemical (ATC) classes are used in both human and
veterinary medicine. [6] In the Netherlands, consumption of
antimicrobials in humans is among the lowest in Europe. [7]
There is also a strict infection control policy in place in most of the
Dutch hospitals, intended to minimize prevalence of antimicrobial
resistant pathogens in Dutch health care facilities. Although this
policy did result in limitation of MRSA prevalence, extended-
spectrum b-lactamase (ESBL)-producing Enterobacteriaceae prev-
alence in the Netherlands is equivalent to most other EU countries
participating in EARSS. [8] Outbreaks in hospitals and other
health care facilities with antimicrobial resistant pathogens are
immediately dealt with, often at high costs. [9–11] In recent years,
the emergence in livestock of antimicrobial resistant bacteria, such
as livestock-associated methicillin-resistant Staphylococcus aureus in
2004 [12,13] and the recent occurrence of ESBL-producing
Enterobacteriaceae in the poultry production chain, led to new
awareness on this issue. [14] It is still unclear to what extent
antimicrobial resistant bacteria in livestock have an impact on the
occurrence of antimicrobial resistant bacteria in humans, or how
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often the reverse is the case, but a recent study showed genetic
similarities between resistant isolates found in chicken meat and
humans. [15] Therefore, it is important to decrease prevalence of
these bacteria in livestock, which can be achieved by, among
others, decreasing antimicrobial usage in these populations. [16].
In 2010, the Dutch government demanded that veterinary
consumption of antimicrobials should decrease to 50% in 2013,
compared to 2009 (http://www.rijksoverheid.nl/documenten-en-
publicaties/kamerstukken/2010/04/09/deskundigenberaad-
rivm-en-reductie-antibioticumgebruik.html). In addition to this,
the Health Council of the Netherlands advised to limit veterinary
consumption of specified antimicrobials in order to preserve them
for human medicine, as these are pivotal antimicrobials (e.g.
fluoroquinolones and 3rd/4th-generation cephalosporins). [17] The
Health Council also advised to consider limitation of all
antimicrobials with selection pressure potential for ESBLs. Thus,
in addition to adaptation of the national veterinary guidelines for
therapy, full transparency of consumption of antimicrobials on
each individual farm was required in combination with a system of
benchmarking. Information on antimicrobial consumption for
individual farms can identify persistent high consumers, who
should give priority to consumption reduction. An independent
institution, the SDa (the Netherlands Veterinary Medicines
Authority), was formed in 2010 with the main purpose of creating
transparency in and setting benchmark indicators for consumption
of antimicrobials in livestock production, based on the consump-
tion data as presented in the present study. Moreover, the SDa
monitors, analyses, and reports data on consumption of antimi-
crobials on a yearly basis, thus making trends in consumption
patterns in the various sectors transparent.
National overall antimicrobials sales data have been reported in
the European Union for several countries for several years through
the European Surveillance of Veterinary Antimicrobial Consump-
tion (ESVAC) project of the European Medicine Agency [18]. So
far, the only country registering and reporting data on sector wide
veterinary consumption of antimicrobials prescribed by veterinar-
ians, is Denmark. [19] These data are collected since 2001 on a
mandatory monthly basis in a central database, VetStat [20], and
reported annually. [21] In these national reports, the calculation
and reporting of antimicrobial drug consumption in animal daily
doses (ADDkg) was done on a national level, comparable to the
human method of defined daily dosage (DDD) calculations.
However, in these reports, no insight is given into the shape and
width of the distribution of farm consumption. Individual farm
data are available and acted upon, when considered necessary, by
the Danish Veterinary and Food Administration. [22].
This paper presents the first unique results of the complete
consumption of antimicrobials as registered on individual farm
level, for all pig, veal calf, and broiler farms in the Netherlands in
2011.
Materials and Methods
Data collection
Data were collected by the respective private animal sectors and
sent to the SDa after encryption of identifiers, thus ensuring the
privacy of the parties concerned. In brief, the data collection
process can be described as follows: each time a veterinarian
prescribes and supplies medicines, information on these deliveries
is entered in Practice Management Systems (PMSs) and
transferred to a central database. The majority of transfers takes
place through VetCIS (www.vetcis.nl), a data hub system set up by
a joint collaboration of the Royal Dutch Veterinary Association
(KNMvD), the main veterinary drug wholesaler in the Nether-
lands AUV, and the association of the veterinary pharmaceutical
industry in the Netherlands (FIDIN). An external audit has been
performed on data entry by the veterinarians, showing that the
maximal margin of error is 10–20%. Data in VetCIS is
subsequently transferred to the private sector databases. This
route accounts for approximately 70% of all transferred
prescriptions. Part of the data is directly transferred from the
PMS to the sector databases or entered by veterinarians through
internet portals of the sector systems. Farmers and veterinarians
have access to the central databases through internet portals to
consult prescription data and consumption of veterinary medi-
cines. The sector data systems are part of existing integral quality
assurance systems, which aim to guarantee food safety for the
consumer. As a part of these systems, each farm is visited at least
once a year for inspection and certification by the private
certifying authorities.
Data entered per medicine delivery includes: a unique farm
identifier (UFI), a unique veterinarian identifier (UVI), EAN code
(unique European Article Number), number of packages supplied,
animal species, animal category, and delivery date. Linked to the
EAN code the following data can be collected as well: REG NL
number (Dutch authorisation number for veterinary pharmaceu-
ticals), ATCvet code, administration route, product name, and
content (including unit) of packaging. Product data are derived
from the so-called Branche Code Table (BCT; provided by
FIDIN). Besides these data, the DDkg (the Defined Dosage of
medicine (g or ml) needed for the treatment of one kilogram of
animal during one day) is derived from the veterinary medicine
criterion (designated DG-standard) and registered in the databas-
es. The DG-standard is a database defining standard doses for
each animal species and route of administration for which an
antimicrobial veterinary medicinal product is licensed in the
Netherlands. In practice, DDkg is derived from the number of
animal kg that, in accordance with the Specification of Product
Characterization (SPC), can be treated with one ml, one gram or
one piece (e.g. intramammary injector) of the specified veterinary
medicinal product (VMP). It is combined with the treatment
duration of this dose. For example: if the authorized dose of a
VMP is 0.01 ml/kg, twice daily, this results in a treatable
weight*days of (100 kg/ml*0.5 days) 50 kgdays per mL. In the
case of a longacting VMP, e.g. 5 days treatment with one shot,
dose again 0.01 ml/kg, this will result in (100 kg/ml*5 days) 500
kgdays per mL. The DG-standard is updated and controlled by
the SDa and available on the website. The average number of
animals present at the farm per year is collected on animal
subcategory level, specified by age groups and farm types.
For the purpose of the first descriptive analyses, the SDa
received a dataset per animal production sector containing a
record for each farm with, besides the animal defined daily
dosages per year (ADDD/Y; for explanation see further), UFI,
UVI, data on the animal species and category, the average
number of animals present on the farm during 2011 (per category
and, where applicable, subcategory), empty barn period (where
applicable; in days), and the period of registration of antimicrobial
deliveries or prescriptions. Pig farms could be included twice in the
dataset; the so-called ‘‘closed farms’’ breed and rear their own
slaughter pigs. For the purpose of this study and benchmarking by
the SDa, these farms were treated as two farm types: production
and slaughter pig farms. All datasets were checked for consistency
and in case of doubt, feedback was asked from the sector
representatives. Where necessary, data were corrected. For veal
calf farms, ADDD/Y were corrected for the periods when the
barns were empty. In the pig husbandry sector, it was agreed that
the - for most fattener pig husbandries consistent - factor of five
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days empty between two rounds of five months (3%), was not
significant enough to correct for. In broilers, the empty period is
already included in the variable ‘‘animal days’’. Coverage of the
number of farms in these databases, related to Statistics Nether-
lands (www.cbs.nl), was 106% for pig farms, 110% for veal calf
farms, and 122% for broiler farms. Discrepancies may be caused
by differences in the definition of ‘‘farm’’ and timing of registration
of the number of farms. On individual farms, the total of
antimicrobial deliveries or prescriptions could be below 0 ADDD/
Y. Reversed entries are made when unused antimicrobials are
returned to the veterinarian or when a wrong entry was made.
For analysis of consumption of specific antimicrobial classes for
each route of administration, the SDa also received prescription
data for the veal calf and pig sectors. For broiler farms, these data
were not yet completely available in sufficient detail and are not
presented.
In these datasets, each veterinary drug delivery on a farm is
recorded, containing, amongst others, identifiers, EAN code,
number of packages, and delivery date. For calculation of ADDD/
Y, prescription data was linked with the other datasets to add the
number of animals present on the farm.
We will further use the term ‘‘antimicrobial consumption’’ as a
synonym for ‘‘antimicrobial delivery’’, as we assume that each
delivery is either consumed by animals, or returned to the
veterinarian and a reversed entry is made for this delivery.
Calculation of ADDD/Y and ATD/Y
The sectors calculated the consumption of antimicrobials per
farm as animal defined daily dosages per year (ADDD/Y); apart
from the denominator this is similar to the standard unit for
consumption of antimicrobials in humans (DDD/1000 days). An
ADDD/Y of 1 means that the average animal in the population
was exposed to an antimicrobial for one day per year. This
measure is similar to that proposed by ESVAC. [23].
To calculate ADDD/Y, two variables are needed. First, the
total animal mass in kg that can be treated for one day with the
amount of antimicrobials supplied to the farmer (treatable
weight*days), which is derived from the DG-standard. Second,
the mean total weight (kg) of animals present on the farm during
2011 (animal weight), which can be calculated according to
standardised mean animal weights (determined per production
type and animal category, see Table 1). By dividing these numbers,
the number of animal daily dosages per year is obtained.
For broilers, ADDD/Y could not yet be determined, because
these data did not include the variables needed to calculate
treatable kilograms. Instead, animal treatment days per year
(ATD/Y) were calculated. One difference between ADDD/Y and
ATD/Y is that the number of treatment days is based on
prescriptions by a veterinarian for a specific age category,
independent of dosage or duration of effectiveness. Another
difference is that the calculation of ATD/Y does not include a
standardised mean weight for the animals. For calculation of
ATD/Y, the numerator was the summation of the number of
treatment days for all broilers present during the year (eg., when
100 animals were each treated for 5 days, the number of treatment
days would be 100*5= 500). The denominator was denoted by the
number of animal days; i.e. the sum of the number of birds present
per day for the year (eg., when during a whole year on average 100
animals are present, the number of animal days is
100*365= 36500). By dividing these numbers and multiplying
by 365, the number of ATD/Y was obtained: the number of days
antimicrobials were administered to broilers on a farm per year (in
our example: (500/36500)*365 = 5).
Statistical analysis
Descriptive statistics were obtained using the MEANS and
FREQ procedures in SASH software version 9.2 (SAS Institute
Inc., Cary, NC, USA). Statistical analyses were performed on the
data by means of the REG and TTEST procedures. We applied
univariate models with ADDD/Y as the dependent variable to test
for the influence of farm characteristics (such as farm size) on
antimicrobial use. R open source software version 2.15.2 (R
Foundation for Statistical Computing, Vienna, Austria) was used
for creating (density) plots.
Results
Farm descriptives
The majority of the 2125 veal calf farms in the data consisted of
white veal calf farms (n= 934, 44%), followed by rose´ finisher
farms (n= 671, 32%), rose´ starter farms (n= 207, 10%), and farms
on which both rose´ starter and finisher calves were present, or a
combination of white and rose´ calves (n = 313, 15%) (figure 1).
There were 14 combination farms in the data with no animals
present; these have been excluded from the results. Registered
farm sizes were diverse, ranging from one animal present in 2011
to over 3000 animals, with mean numbers of 606 (white veal), 285
(rose´ starter), 210 (rose´ finisher), and 437 (combination) animals
per farm. There were 2528 production farms with sows and piglets
in the data, and 5531 farms where slaughter pigs were kept. Two
production farms had no animals in 2011; these have been
excluded from further results. Again, registered pig farm sizes
varied greatly, ranging from 2 sows to over 4000 for production
farms, and from 2 slaughter pigs to 13000 for slaughter pig farms.
Mean number of sows for production farms was 382, and for
Table 1. The applied standardised mean animal weight and treatment weight per animal category and age category (adapted
from http://www.autoriteitdiergeneesmiddelen.nl/Userfiles/rapportage--sda-expertpanel-dataanalyse-2011-en-
benchmarkindicatoren-2012.pdf).
Animal species Farm category Age Standardised mean weight
Veal calf White 0 – 222 days 160 kg
Rose´ starter 0 – 98 days 77.5 kg
Rose´ finisher 98 – 256 days 232.5 kg
Pig Production with sows and piglets Combination of ages 303.8 kg*
Slaughter 74 – 191 days 70 kg
*Combination of 1 sow (of 220 kg) + 5.5 piglets (of 12.5 kg each) + 0.14 gilts (of 107.5 kg each).
doi:10.1371/journal.pone.0077525.t001
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slaughter pig farms 1092 animals. The 732 broiler farms ranged
from 620 to 434106 (mean: 67745) broilers.
Antimicrobial consumption
The distributions of ADDD/Y and ATD/Y per farm are shown
in Figures 1, 2, 3 for the various livestock categories. The
distributions for white and rose´ starter farms showed a large spread
in ADDD/Y values. With exception of rose´ starter farms, all
distributions were highly skewed to the right and showed a long
tail.
Table 2 shows the arithmetic and geometric means and
standard deviations, and the median and 75th percentile (P75)
for ADDD/Y for veal calf and pig farms, and ATD/Y for broiler
farms. The highest arithmetic mean and median ADDD/Y were
found in rose´ starter farms (arithmetic mean/median ADDD/Y
= 105.4/83.2, P75 = 110.0, 90th percentile (P90) = 149.5), and
the lowest arithmetic mean and median ADDD/Y in rose´ finisher
farms (arithmetic mean/median ADDD/Y = 5.2/1.2, P75 =
6.0, P90 = 13.1). White veal calf farms had an intermediate
consumption of antimicrobials (arithmetic mean/median ADDD/
Y = 35.6/28.6, P75 = 38.9, P90 = 50.7). ADDD/Y values were
not calculated for combination farms, because of their complex
nature with regards to the categories of calves present.
In the pig sector, the arithmetic mean/median ADDD/Y were
16.9/9.3 (P75 = 20.8, P90 = 40.6) and 9.6/3.0 (P75 = 10.8,
P90 = 22.5) for production and slaughter pig farms, respectively.
Broiler farms had an arithmetic mean/median ADT/Y of 23.8/
20.9 (P75 = 34.1, P90 = 50.0).
Figure 1. Frequency distribution of ADDD/Y per veal calf farm ranging from 0 to 150. The line demonstrates a density plot based on the
histogram. Number of farms with ADDD/Y.150: 27 (white: 7, rose´ start: 20) and number of farms with ADDD/Y,0: 4 (white: 3, rose´ finisher: 1).
doi:10.1371/journal.pone.0077525.g001
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No univariate significant association was found between
consumption of antimicrobials and the number of veal calves
present as a continuous variable (p-values . 0.1), or as a
categorical variable (smaller or larger than the median, p-values .
0.09). However, for the number of pigs present on the farm, a
positive significant univariate association with consumption of
antimicrobials was found (production farms: b=0.012, 95%
Confidence Interval (CI): 0.006 – 0.019, p , 0.01; slaughter pig
farms: b=0.0017, 95% CI: 0.0007 – 0.003, p , 0.01). A similar
result was seen for production pig farms when analysing number of
pigs as a categorical variable depending on the median. For the
number of broilers present on the farm, a significant, albeit small,
positive association with consumption of antimicrobials was found
as well (b=0.00006, 95% CI: 0.00004 – 0.00009, p , 0.01).
In figure 4 an overview is given of the mean consumption of
antimicrobials per farm category in the pig and veal calf sectors,
for specified ATCvet groups. The figure shows that tetracyclines
were overall the most used antimicrobial group, followed by
trimethoprim/sulfonamides and macrolides/lincosamides.
On 39% of 934 white veal calf farms, 3rd/4th-generation
cephalosporins were consumed in 2011, with a P75 of 0.07
ADDD/Y. Fluoroquinolones were administered orally on 59% of
the white veal calf farms (P75 = 0.32 ADDD/Y), and parenterally
on 87% of these farms (P75 = 0.34 ADDD/Y). Rose´ starter and
finisher calf farms hardly used 3rd/4th-generation cephalosporins
(13%/10% of 207 starter and 665 finisher farms, respectively, with
P75 = 0 ADDD/Y). Fluoroquinolones were administered on
most rose´ starter farms in 2011 (40% of the farms orally: P75 =
Figure 2. Frequency distribution of ADDD/Y per pig farm ranging from 0 to 150. The line demonstrates a density plot based on the
histogram. Number of farms with ADDD/Y.150: 15 (sows: 3, finishers: 12) and number of farms with ADDD/Y,0: 1 (finisher: 1).
doi:10.1371/journal.pone.0077525.g002
Figure 3. Frequency distribution of ATD/Y per broiler farm ranging from 0 to 150. The line demonstrates a density plot based on the
histogram. Number of farms with ATD/Y.150: 0 and number of farms with ATD/Y,0: 0.
doi:10.1371/journal.pone.0077525.g003
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0.50 ADDD/Y, and 75% parenterally: P75 = 0.99 ADDD/Y),
but hardly on rose´ finisher farms (2% of the farms orally: P75 = 0
ADDD/Y, and 24% parenterally: P75 = 0 ADDD/Y).
Consumption of these antimicrobials was low on pig farms. On
22% (P75 = 0 ADDD/Y) and 4% (P75 = 0 ADDD/Y) of 2494
production and 5441 slaughter pig farms 3rd/4th-generation
cephalosporins were administered, respectively. Fluoroquinolones
were administered orally on 4% (P75 = 0 ADDD/Y) and 0.1%
(P75 = 0 ADDD/Y) of the production and slaughter pig farms,
respectively. Parenterally, these antimicrobials were administrated
on 36% (P75 = 0.04 ADDD/Y) and 8% (P75 = 0 ADDD/Y) of
the pig production and slaughter pig farms.
Discussion
The unique data presented in this study represent the first time
that consumption of antimicrobials, in the form of prescriptions
and/or deliveries on the farm, is available on this level for each
pig, veal calf, and broiler farm in the Netherlands. The data show
that large differences exist between farms within the different
categories regarding consumption of antimicrobials. Consumption
also greatly varies between farm categories. In most categories
analysed here, the majority of farms have low consumption of
antimicrobials. However, a minority of farms have a very high
ADDD/Y. The insights obtained from these data aid the SDa with
their aim to define benchmark criteria for antimicrobial
Table 2. Arithmetic mean and standard deviation, and geometric mean and standard deviation of ADDD/Y for veal calf and pig
farms, and of ATD/Y for broiler farms.
Animal species Farm category Arithmetic mean
Arithmetic standard
deviation Median P75 Geometric mean*
Geometric
standard
deviation*
Veal calf All active farms** 32.2 125.4 19.7 35.6 8.1 9.0
White 35.6 111.5 28.6 38.9 23.2 3.1
Rose´ starter 105.4 159.1 83.2 110.0 52.5 6.5
Rose´ finisher 5.2 10.9 1.2 6.0 1.1 7.2
Pig Production with sows and
piglets
16.9 58.9 9.3 20.8 6.3 5.8
Slaughter 9.6 48.0 3.0 10.8 1.8 8.4
Poultry Broiler 23.8 20.6 20.9 34.1 9.9 7.5
*In order to calculate the natural log, ADDD/Y # 0 was set at 0.1.
**Farms where no animals were present were excluded, 2111 farms are included in this category.
doi:10.1371/journal.pone.0077525.t002
Figure 4. Mean ADDD/Y per farm per animal sector, given for 13 ATCvet classes.
doi:10.1371/journal.pone.0077525.g004
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consumption, which should ultimately lead to reduction in
consumption.
ADDD/Y is a measure for the number of days on a farm
antimicrobials have been administered. It is important to realize
that this does not mean that each and every animal has received
that calculated ADDD/Y, but that it in fact is a measure per
animal position available on the farm. ADDD/Y is also based on
standard doses as determined by the SDa, which in general is the
mean dose according to the Specification of Product Character-
ization (SPC) of the specific veterinary medicinal product. In
reality, under- or overdosing may occur frequently. [24] Other
factors influencing the calculated ADDD/Y include in the
numerator long acting products and in the denominator the
selection of the average weight (such as the combination of sows
and piglets). For long acting products a treatment duration factor
is added to the ADDD calculation (for instance a single shot of a
product acting for 5 days results in 5 times the number of ADDD
compared to a single shot of a direct acting drug).
On mixed farms, such as combination veal calf farms (with both
rose´ and white veal calves present) and ‘‘closed’’ pig farms (with
both sows and piglets and slaughter pigs), it is possible that
antimicrobials have not been registered for the correct animal
category. This may lead to misclassification and a biased ADDD/
Y per farm. However, this effect is expected to be small over a
farm category. In the current analyses, closed pig farms have been
included as two farms, and combination veal farms have been
ignored. In future analyses, these farms will be considered as
distinct farm categories.
Clear differences exist in antimicrobial consumption between
animal sectors and farm categories, but these are difficult to
compare due to differences in farm management. The veal calf
sector has a higher consumption, which might be a consequence of
the way calves are collected. Veal calf farms receive calves from
dairy farms from the Netherlands (approximately 50%) and
countries throughout Europe (predominantly Germany). These
calves are a product of the dairy industry. [25] Sober calves arrive
once or twice a year (usually an all-in, all-out system is applied),
after transport often creating an optimal atmosphere for pathogen
transmission. Frequently, calves receive antimicrobial treatments
in the first few weeks after arrival, which means that farms with
two production cycles in a year, likely will have a higher ADDD/Y
then farms with only one starting phase of a production cycle in
that particular year. [24–26].
Dutch pig farms have more closed production systems than veal
calf farms, or have animal supply from limited sources. In broilers,
infection control is well possible by hygienic measures between
production rounds. However, broiler production in the Nether-
lands is not integrated in production chains that include breeders,
hatcheries and broiler farms. As a result, infection control is also
not optimally integrated along these production chains. Currently,
best practices to control infectious diseases and the health status of
animals is a priority in the Netherlands, both within animal
production sectors and within the veterinary society.
Comparisons between animal sectors or farm categories should
be made with care because of the influence of animal weight on
the calculated ADDD/Y. Calculation of ADDD/Y is based on a
standardised average weight for animals. For adult animals, e.g.
sows, this weight will be steady over the course of a year, but for
fattener animals, e.g. white veal calves and slaughter pigs, this
weight will strongly increase during the production cycle. Recent
studies showed that the majority of antimicrobial use in pigs is
administered before they are 10 weeks of age, i.e. at lower weight,
which is comparable to treatments in veal calves. [26,27] For the
category of white veal calves and slaughter pigs, depending on the
exact timing of the treatment over- but more likely underestima-
tion of the ADDD/Y can occur. Use of actual weights during
treatment could improve the ADDD/Y estimate but requires a
more detailed and accurate registration. [24].
To date, Denmark is the only other country publishing
antimicrobial consumption figures annually, based on prescrip-
tions by veterinarians, for all farms in an animal sector. [21,28] In
the DANMAP reports, antimicrobial drug consumption is
presented as animal daily doses (ADDkg), related to total
biomass-year-at-risk, kg-meat-produced, or number of animals
produced. ADDkg is given for each age-group and species, e.g.
piglets, weaners, fattening pigs or sows, but no mean farm ADD is
reported in the reports. [19] Denmark does, however, calculate
farm level ADDs for their ‘‘yellow card’’ system, which is designed
to control veterinary antimicrobial consumption. [22] In this
system, pig farms are given a ‘‘yellow card’’ when they consume
more than twice the average consumption. Farms with a ‘‘yellow
card’’ have to implement antimicrobial restrictive measures.
The European Medicines Agency is currently considering which
technical units of measurements and indicators should be used for
future collection of and reporting on national veterinary antimi-
crobial drug consumption, as part of the European Surveillance of
Veterinary Antimicrobial Consumption project. [23] Although
this will provide valuable information on national level, neither the
proposed ESVAC indicators for the near future nor the DANMAP
indicators as reported up till now, consider the practical and
methodological implications of the wide distribution of antimicro-
bial consumption on farms, as shown in this paper. Our farm level
data, reporting on all individual farms nationwide, create a
breakthrough in analytical possibilities and benchmarking options,
as we clearly demonstrate that normal distribution statistics are not
appropriate for describing or analysing antimicrobial consump-
tion, and that differences in consumption of antimicrobial agents
amount to one, sometimes two orders of magnitude between
farms.
In previous years, veterinary consumption of antimicrobials in
the Netherlands was reported for a selection of farms (based on
stratified sampling) and in terms of total national sales data. [1,29]
Bondt et al. used national sales data to compare veterinary
antimicrobial exposure between Denmark and the Netherlands,
demonstrating that data on consumption per animal species is a
necessity to be able to adequately compare countries. [30] When
comparing our data (table 2) with those of the MARAN-report on
2011, we demonstrate that outcomes based on a sample of farms
may give a biased estimate of antimicrobial consumption. [31]
The MARAN-report shows consistently lower results when
comparing to the arithmetic means in table 2. The mean
arithmetic consumption in daily doses per animal year (DD/AY)
reported by MARAN is 13 (95% CI: 10 – 16) for pig production
farms, 8 (95% CI: 5 – 11) for slaughter pig farms, 25 (95% CI: 23 –
26) for veal calf farms, and 16 (95% CI: 12 – 21) for broiler farms.
However, when we compare the MARAN results with our
calculated geometric means, our results are much lower. This
shows that the long right tail in the distributions strongly influences
the average consumption in a farm category, and emphasizes the
need for reporting distributions of consumption on farm level. The
use of a disproportional stratified random sampling design for the
MARAN-report probably also affected the outcomes, where the
weighted results of a selection of farms are extrapolated to the
whole sector.
So far, the reason for the large and right skewed between-farm
spread in consumption of antimicrobials is unknown. In veal calf
farms the number of production cycles started in 2011, may have
contributed to the skewedness of the distribution, as younger calves
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are more susceptible to infections and therefore will receive more
treatments with antimicrobials. This may lead to a relatively
higher consumption in farms with more production cycles in a
year. A similar wide between-farm spread has been shown by
other studies. [2,32] For slaughter pig farms, farm system (farrow-
to-finish or specialized slaughter pig farms) and number of pigs
were shown to influence consumption of antimicrobials, and for
sow farms this was farm system (specialized sow farm), number of
sows and regional population density. [2] We analysed the
influence of farm size on consumption of antimicrobials, as earlier
reports on Dutch sentinel farms found an association in pig
production (but not in poultry). [3] In our data, this association
was found to be significant for the pig and broiler farms, but in
univariate analyses only, therefore not accounting for the influence
of other factors. The influence of farm size needs to be studied in
more detail.
For 2012, the SDa have defined benchmark action criteria for
antimicrobial consumption. Because of the wide distributions, the
initial aim is to limit the tail of the distribution, and benchmarks
focus at the 75th percentile of the consumption in 2011. Farms that
exceed these benchmarks are obliged to promptly undertake
measures to decrease their consumption of antimicrobials.
Moreover, in general median consumption in 2011 minus 20%
was defined as the upper limit for the target benchmark criterion
for appropriate antimicrobial consumption. This target will be re-
evaluated in 2015. The benchmark criterion for action will
annually be re-evaluated, because it is anticipated that removing
the long tail in the population will have a major impact on the
average consumption in a sector. When all farms above the action
benchmark criterion reduce their antimicrobial consumption to
the upper limit of the target benchmark criterion, the overall
decrease of antimicrobial consumption in each of the farm
categories will be substantial. Early 2013, data for 2012 have
become available that will allow the evaluation of the achieved
reduction and persistent high users. Data on broiler farms will be
provided similar to the other animal sectors, facilitating calculation
of ADDD/Y for broiler farms instead of ATD/Y. In addition,
antimicrobial prescription behaviour will also be monitored on the
level of veterinarians.
In conclusion, the analysis of unique data provided to the SDa
by the animal sectors in the Netherlands, shows that consumption
of antimicrobials varies strongly between animal production
sectors and farm categories, and also within farm categories.
The wide and skewed distribution in consumption has important
methodological implications for benchmarking, surveillance, and
future analyses of trends over the years within farms, within animal
sectors, and between animal sectors. The full transparency
obtained on antimicrobial consumption per farm, as shown in
the data collected for the SDa, enables targeted measures to
reduce and improve the quality (in terms of very restricted
antimicrobial use of specified groups like fluoroquinolones and
cephalosporins) of antimicrobial consumption, and serves as a tool
for both farmers and veterinarians. These will include measures to
improve health status and control of infectious diseases on those
farms where consumption of antimicrobials is (consistently)
highest. This should result in optimal reduction of antibiotic
consumption combined with improved health control. In the
following years, the SDa will report on within-(sub)sector trends,
expanding to other animal sectors, as well as on within-farm trends
and trends on prescriptions by veterinarians.
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